Overexpression of MMP-2 and MMP-9 was linked to poor prognosis in oral cancer [37], lung cancer [38], breast cancer [39], retinoblastoma [40], bladder cancer [41], and ovarian epithelial cancer [42]. This evidence concerns the gene MMP9 and breast cancer.